Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  1999-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.ATV.19.10.2563PMID 10521388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibrin-Rich and Platelet-Rich Thrombus Formation on Neointima: Recombinant Tissue Factor Pathway Inhibitor Prevents Fibrin Formation and Neointimal Development following Repeated Balloon Injury of Rabbit Aorta

  1998cited by this paper
• Regulation of Extrinsic Pathway Factor Xa Formation by Tissue Factor Pathway Inhibitor*

  1998cited by this paper
• Human recombinant tissue‐factor pathway inhibitor prevents the proliferation of cultured human neonatal aortic smooth muscle cells

  1997cited by this paper
• Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs.

  1997cited by this paper
• Dissociation of Antithrombotic Effect and Bleeding Time Prolongation in Rabbits by Inhibiting Tissue Factor Function

  1997cited by this paper
• Tissue Factor Pathway Inhibitor Inhibits Aortic Smooth Muscle Cell Migration Induced by Tissue Factor/Factor VIIa Complex

  1997cited by this paper
• Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor- dependent coagulation pathway

  1996cited by this paper
• Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathway.

  1996cited by this paper
• Association of endothelial tissue factor and thrombomodulin with caveolae.

  1996cited by this paper
• Receptor-mediated Endocytosis of Coagulation Factor Xa Requires Cell Surface-bound Tissue Factor Pathway Inhibitor (*)

  1996cited by this paper
• Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rat.

  1996cited by this paper
• Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits.

  1995cited by this paper
• Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model.

  1995cited by this paper
• Refold and Characterization of Recombinant Tissue Factor Pathway Inhibitor Expressed in Escherichia coli

  1994cited by this paper
• Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits.

  1994cited by this paper
• New Antithrombotic Strategies for Resistant Thrombotic Processes

  1994cited by this paper
• Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.

  1993cited by this paper
• Tissue factor is rapidly induced in arterial smooth muscle after balloon injury.

  1993cited by this paper
• Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells.

  1992cited by this paper
• Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa.

  1992cited by this paper
• Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.

  1992cited by this paper
• The lipoprotein-associated coagulation inhibitor.

  1991cited by this paper
• Thrombin and other potential mechanisms underlying restenosis.

  1991cited by this paper
• The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty.

  1991cited by this paper
• Effectiveness of Recombinant Desulphatohirudin in Reducing Restenosis After Balloon Angioplasty of Atherosclerotic Femoral Arteries in Rabbits

  1991cited by this paper
• Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein.

  1990cited by this paper
• Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action.

  1990cited by this paper
• Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

  1989cited by this paper
• Evidence for the presence of tissue factor activity on subendothelium.

  1989cited by this paper
• Modifications of Extrinsic Pathway Inhibitor (EPI) and Factor Xa that Affect their Ability to Interact and to Inhibit Factor Vila/Tissue Factor: Evidence for a Two-Step Model of Inhibition

  1988cited by this paper
• Restenosis after successful coronary angioplasty. Pathophysiology and prevention.

  1988cited by this paper
• The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action

  1988cited by this paper
• The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.

  1988cited by this paper
• Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium.

  1983cited by this paper
• Purification and properties of human coagulation factor VII.

  1980cited by this paper

• Deletion of Tissue Factor Pathway Inhibitor Isoform Beta or Gamma, but not Alpha, Improves Clotting in Hemophilia Mice.

  2024cites this paper
• Effect of tissue factor pathway inhibitor on the pyroptosis of vascular smooth muscle cells induced by angiotensin II

  2024cites this paper
• Knockdown and Knockout of Tissue Factor Pathway Inhibitor in Zebrafish

  2021cites this paper
• TFPI (Tissue Factor Pathway Inhibitor)

  2018cites this paper
• Conditional knockout of TFPI-1 in VSMCs of mice accelerates atherosclerosis by enhancing AMOT/YAP pathway.

  2017cites this paper
• IN VIVO STUDIES OF CELL-FREE DNA AND DNASE IN A MURINE MODEL OF POLYMICROBIAL SEPSIS

  2016cites this paper
• The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis.

  2013cites this paper
• Factor VII–Activating Protease Promotes the Proteolysis and Inhibition of Tissue Factor Pathway Inhibitor

  2012cites this paper
• Identification and analysis of the tissue factor pathway inhibitor 2 of Sciaenops ocellatus.

  2011cites this paper
• A new tick Kunitz type inhibitor, Amblyomin-X, induces tumor cell death by modulating genes related to the cell cycle and targeting the ubiquitin-proteasome system.

  2010cites this paper
• A new Factor Xa inhibitor from Amblyomma cajennense with a unique domain composition.

  2010cites this paper
• Delivery of TFPI-2 using ultrasound with a microbubble agent (SonoVue) inhibits intimal hyperplasia after balloon injury in a rabbit carotid artery model.

  2010cites this paper
• Identification and characterization of murine alternatively spliced tissue factor

  2006cites this paper
• The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.

  2006cites this paper
• Tissue factor pathway inhibitor: structure, biology and involvement in disease

  2006cites this paper
• Tifacogin, Recombinant Tissue Factor Pathway Inhibitor

  2005cites this paper
• Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity.

  2004cites this paper
• Mice deficient in tissue factor demonstrate attenuated intimal hyperplasia in response to vascular injury and decreased smooth muscle cell migration

  2004cites this paper
• Penthalaris, a novel recombinant five-Kunitz tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick vector of Lyme disease, Ixodes scapularis

  2004cites this paper
• Update in atherothrombotic disease.

  2004cites this paper
• MCP-1 deficiency is associated with reduced intimal hyperplasia after arterial injury.

  2003cites this paper
• Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects.

  2002cites this paper
• Tissue factor and coronary artery disease.

  2002cites this paper
• Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex.

  2002cites this paper
• The Expression of Tissue Factor and Tissue Factor Pathway Inhibitor in Aortic Smooth Muscle Cells Is Up-regulated in Synthetic Compared to Contractile Phenotype

  2002cites this paper
• Pharmacological Intervention at Disparate Sites in the Coagulation Cascade: Comparison of Anti-thrombotic Efficacy vs. Bleeding Propensity in a Rat Model of Acute Arterial Thrombosis

  2002cites this paper
• The role of tissue factor/factor VIIa in the pathophysiology of acute thrombotic formation.

  2001cites this paper
• Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis.

  2001cites this paper
• Structure and Biology of Tissue Factor Pathway Inhibitor

  2001cites this paper
• Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries

  2001cites this paper
• Topically applied tissue factor pathway inhibitor reduced intimal thickness of small arterial autografts in rabbits.

  2001cites this paper
• HIV envelope gp120 activates human arterial smooth muscle cells

  2001cites this paper
• Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences

  2001cites this paper
• Pretreatment of a Dacron Graft with Tissue Factor Pathway Inhibitor Decreases Thrombogenicity and Neointimal Thickness: A Preliminary Animal Study

  2001cites this paper
• Tissue factor pathway inhibitor for cardiovascular disorders

  2000cites this paper
• Tissue factor-dependent factor VIIa signaling.

  2000cites this paper